US Stock MarketDetailed Quotes
RVNC Revance Therapeutics
- 5.810
- +0.010+0.17%
Close Nov 4 16:00 ET
- 5.820
- +0.010+0.17%
Post 17:02 ET
605.29MMarket Cap-1804P/E (TTM)
5.850High5.640Low1.02MVolume5.800Open5.800Pre Close5.91MTurnover1.13%Turnover RatioLossP/E (Static)104.18MShares9.74552wk High-4.67P/B526.18MFloat Cap2.30052wk Low--Dividend TTM90.56MShs Float42.410Historical High--Div YieldTTM3.62%Amplitude2.300Historical Low5.766Avg Price1Lot Size
Revance Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Nov 4, 2024
The average Revance Therapeutics stock price target is 9.32 with a max estimate of 25.00 and a min estimate of 6.60
Review Revance Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Analysis
Price Target
Updated: Nov 4, 2024
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data